Nalmefene enhances the remyelinating ability of nalfurafine when administered therapeutically at very low doses during experimental autoimmune encephalomyelitis

Abstract Objectives Multiple sclerosis is an immune‐mediated inflammatory disease of the central nervous system. Recently, kappa opioid receptor (KOR) agonists were found to promote remyelination and recovery in models of demyelination. However, the side effects of many full KOR agonists limit clini...

Descripción completa

Detalles Bibliográficos

Autores principales:	Lisa Denny, Katharina Robichon, Nikki Templeton, Mackenzie Kiernan, Thomas E Prisinzano, Bronwyn M Kivell, Anne Camille La Flamme
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2025-01-01
Colección:	Clinical & Translational Immunology
Materias:	experimental autoimmune encephalomyelitis kappa opioid receptor agonist mu opioid receptor antagonist nalfurafine nalmefene
Acceso en línea:	https://doi.org/10.1002/cti2.70069
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!